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2ABSTRACT. Due to the critical role of the large neutral amino acid transporter-1 (LAT-1) in
promoting tumor growth and proliferation, it is fast emerging as a highly attractive biomarker
for the imaging and treatment of human malignancies, including breast cancer. Whilst multi-
branched gold nanoparticles (AuNPs) have emerged as a promising modality in the
photothermal therapy (PTT) of cancers, some of the key challenges limiting their clinical
translation lies in the need to develop reproducible and cost-effective synthetic methods as
well as the selective accumulation of sufficient AuNPs at tumor sites. In this study, we report
a simple and direct seed-mediated synthesis of monodispersed multi-branched AuNPs using
the catechol-containing LAT-1 ligands, L- and D-dopa, to confer active cancer targeting. This
route obviates the need for additional conjugation with targeting moieties such as peptides or
antibodies. Nanoflower-like AuNPs (AuNF) with diameters of approximately 46, 70 and 90
nm were obtained and were found to possess excellent colloidal stability and biocompatibility.
A significantly higher intracellular accumulation of the L- and D-dopa functionalized AuNFs
was observed in a panel of breast cancer cell lines (MCF-7, MDA-MB-231, MDA-MB-468,
and MDA-MB-453) when compared to the non-targeting control AuNFs synthesized with
dopamine and 4-ethylcatechol. Importantly, no significant difference in uptake between the
targeting and non-targeting AuNFs was observed in a non-tumorigenic MCF-10A breast
epithelial cell line, hence demonstrating tumor selectivity. For PTT of breast cancer, Ag+ was
introduced during synthesis to obtain L-dopa functionalized nanourchin-like AuNPs (AuNUs)
with strong near infrared (NIR) absorbance. The L-dopa functionalized AuNUs mediated
selective photothermal ablation of the triple negative MDA-MB-231 breast cancer cell line
and sensitized the cells to the anticancer drugs cisplatin and docetaxel. This work brings
3forward an effective strategy for the facile preparation of cancer targeting multi-branched
AuNPs with potential for the in vivo PTT of breast cancer.
1. Introduction
Breast cancer is the most common cancer among women and is one of the leading causes
of morbidity and mortality worldwide.1 Triple negative breast cancers (TNBCs), in particular,
pose a major clinical challenge as they are refractory to the various targeted hormonal
therapies available and have a high risk of recurrence.2 In recent years, photothermal therapy
(PTT) in which light energy is converted into heat, has emerged as a promising treatment
modality for the minimally invasive treatment of various cancers such as breast cancer, gastric
cancer, head and neck cancer, and melanoma. Anisotropic gold nanoparticles (AuNPs) such
as nanorods, nanoprisms, nanostars, and nanoplates have been the focus of intense research as
PTT mediators due to their strong localized surface plasmon resonance (LSPR) effect, ease of
synthesis and functionalization, excellent biocompatibility, and potential to be simultaneously
used as contrast enhancement agents for non-invasive X-ray computed tomography (CT) and
photoacoustic imaging.3-5 Additionally, the longitudinal LSPR peak of anistropic AuNPs can
be readily tuned to the near infrared (NIR) region (650 – 900 nm) to correspond to the
biologically transparent window in which tissues and blood minimally absorb. This property
enables the use of NIR lasers with deeper light penetration to selectively mediate
photothermal ablation of tumors that have taken up the nanoparticles, hence minimizing
damage to surrounding tissues. The combination of PTT with conventional chemotherapy has
since been proposed as an attractive therapeutic approach to improve antitumor efficacy and
minimize side effects.4, 6
4Despite their promise, one of the key factors limiting the successful clinical translation of
AuNP-mediated PTT lies in the poor in vivo accumulation of nanoparticles at tumor sites.4
AuroShell® (Nanospectra Biosciences), which are silica nanoparticles coated with thin
PEGylated gold shells, currently represent the only AuNP-based PTT device that has been
evaluated in clinical trials.4, 7-8 Whilst encouraging patient responses were observed in Phase I
and II clinical trials for recurrent/refractory head and neck cancer, primary and metastatic
lung cancer, and prostate cancer, it was found that only 1% of the injected dose achieved
tumor accumulation as the nanoparticles relied solely on the enhanced permeation and
retention (EPR) effect to passively accumulate in the tumor. It could thus be envisaged that
the incorporation of active targeting strategies to increase tumor accumulation of AuNPs
could potentially lead to enhanced antitumor effects, less side effects, and reduced treatment
costs during PTT. In this regard, numerous researchers have successfully investigated the
surface conjugation of pre-synthesized AuNPs with macromolecules such as cell penetrating
or targeting peptides, aptamers, antibodies or nanobodies for active targeting to cell surface
receptors or molecules that are frequently overexpressed in cancer cells or its
microenvironment.4 Such approaches, however, often involve time-consuming chemical
conjugation, purification, and characterization procedures, as well as the use of expensive
cross-linkers, peptides and/or monoclonal antibodies which may not be ideal in the large scale
commercial synthesis of AuNPs for clinical use.4, 9 The continued development of facile
synthetic methods to reproducibly obtain monodispersed cancer targeting AuNPs will
therefore be key for their successful clinical translation as effective photothermal agents. At
the same time, the targeting of novel receptors or transporters that are consistently
overexpressed in different cancer types, staging, and sub-types provides advantages for the
broad utility of these novel devices in the selective photothermal ablation of a wide range of
malignancies.
5The large neutral amino acid transporter 1 (LAT-1) forms a functional heterodimeric
complex with 4F2hc (or CD98) heavy chain to transport a wide range of branched or aromatic
amino acids and their related drugs such as leucine, phenylalanine, tryptophan, L-dopa,
triiodothyronine, and melphalan in a sodium-independent manner.10 It plays a crucial role in
facilitating amino acid uptake for protein synthesis, metabolic activities, and regulation of
complex signaling pathways in rapidly dividing tumor cells and thus has been found to be
overexpressed in the majority of human neoplasms.11 Particularly in breast cancers, LAT-1
has been found to be frequently overexpressed in tumor cells, with little or no expression in
normal mammary ducts or adjacent breast tissues, and its co-expression with 4F2hc is
correlated with poor disease prognosis in the triple-negative subtype.12-13 Given its important
role in promoting tumor proliferation, the LAT-1 represents a highly attractive, but yet poorly
exploited, biomarker for the imaging and treatment of breast cancers.12, 14 Recently, the
effectiveness of targeting LAT-1 for anticancer drug delivery to breast cancer and glioma was
reported by Li et al..15-16 It was demonstrated that the use of LAT-1 targeting glutamate-
functionalized polyoxyethylene stearate PLGA nanoparticles to deliver paclitaxel led to
significantly higher tumor accumulation and inhibition of tumor growth in a subcutaneous
4T1 breast carcinoma mouse tumor model compared to the non-targeting control
nanoparticles.15
Based on these observations, we hypothesized that the incorporation of LAT-1 targeting
moieties on AuNPs would selectively increase nanoparticle accumulation inside tumor cells
for the PTT of breast cancer. At the same time, the judicious choice of a reducing-cum-
capping agent can simultaneously give rise to multi-branched AuNPs and present the primary
amine, carboxylic acid, and bulky side groups that are requisite for interaction with the LAT-
1.10 This direct synthesis of multi-branched AuNPs is expected to offer significant time and
cost savings in the preparation of active targeting AuNPs for PTT. To achieve this, we
6focused on the seed-mediated synthesis of monodispersed multi-branched AuNPs using the
LAT-1 ligands L- and D-dopa as reducing-cum-capping agents to confer intrinsic LAT-1
targeting properties, without the need for addition conjugation steps or the traditional use of
cytotoxic surfactants such as cetrimonium bromide. L- and D-dopa belong to the catechol
class of compounds which consists of two hydroxyl groups bonded to a benzene ring in the
ortho position. During oxidation, the two hydroxyl groups in the catechol lose four electrons
to form quinones and are therefore capable of reducing the AuCl4
- species to produce gold
atoms.17-18 In this study, in order to improve the uniformity of the synthesized multi-branched
AuNPs for PTT, the reduction process was conducted in the presence of pre-formed gold
seeds which served as catalysts to promote the reduction of AuCl4
- by the catechols and
enable the selective deposition of gold atoms onto the surface of the metal clusters, thus
avoiding secondary nucleation.19-20 Given the structural similarity of catechols to
hydroquinone (another hydroxylated aromatic), it is likely that the former similarly promoted
preferential deposition of gold atoms onto the active (111) facets in a kinetically driven
manner, thereby giving rise to nanoparticles with a multi-branched nanoflower-like growth.21-
22 For a valid comparison of active targeting properties, non-targeting AuNPs with
comparable multi-branched morphologies were synthesized using dopamine and 4-
ethylcatechol, which similarly belong to the catechol class but do not fully possess the
IXQFWLRQDO JURXSV UHFRJQL]HG E\ WKH /$7 LH ERWK ĮDPLQR DQG ĮFDUER[\OLF DFLG
groups10). The cytotoxicities and cellular targeting capabilities of the synthesized AuNPs were
first evaluated in a panel of breast cancer cell lines (MCF-7, MDA-MB-231, MDA-MB-468,
and MDA-MB-453) and a non-tumorigenic breast epithelial MCF-10A cell line. The
functional versatility of this system for PTT was further demonstrated by tuning the LSPR
peak of the synthesized AuNPs to the NIR region by exploiting the underpotential deposition
effect of silver ions to increase the aspect ratios of the branches,23-25 yielding sea urchin-like
7AuNPs (AuNUs). The targeted PTT mediated by the AuNUs alone as well as combination
with chemotherapeutic drugs cisplatin and docetaxel were investigated in the triple negative
MDA-MB-231 metastatic breast cancer cell line. Taken together, this study offers a new
perspective on the facile preparation of multi-branched AuNPs with intrinsic LAT-1 targeting
capabilities for the photothermal treatment of breast cancer.
2. Experimental Section
2.1. Materials: Gold (III) chloride trihydrate, L-3,4-dihydroxyphenylalanine (L-dopa),
dopamine hydrochloride, 4-ethylcatechol, poly(ethylene glycol) methyl ether thiol (mPEG
thiol) average Mn 6,000, and silver nitrate were purchased from Sigma Aldrich. D-3,4-
dihydroxyphenylalanine (D-dopa) was obtained from Santa Cruz Biotechnology. All reagents
were used as received without further purifications. The LIVE/DEAD® Viability/Cytotoxicity
.LWZDVSXUFKDVHGIURP7KHUPR)LVKHU6FLHQWLILF0LOOL4ZDWHU0ȍāFPUHVLVWLYLW\DW
25 °C) was used for the cleaning of glassware and the synthesis of AuNPs.
2.2. Synthesis of AuNPs: 2.2.1. Preparation of Au seeds. All glassware and stir bars were
thoroughly cleaned with aqua regia (HCl:HNO3, 3:1 v/v) before use. Spherical gold seeds with
a diameter of approximately 14 nm were first prepared by adding 300 µL of 388 mM sodium
citrate to 100 mL of boiling 3.0 × 10-1 mM HAuCl4·3H2O solution under stirring. The mixture
was kept boiling for 15 min until a wine red color was observed. The resultant citrate-capped
AuNPs were pelleted by centrifugation (10,016 × g for 2 h) and rinsed thrice with Milli-Q
water to remove excess reagents.
2.2.2. Synthesis of catechol-functionalized nanoflower-like AuNPs (AuNFs). In a typical
synthesis of 90 nm catechol-functionalized AuNFs, 100 µL of 0.1 M HAuCl4·3H2O, 144 µL
of 3.8 × 10-1 mM spherical gold seeds, 400 µL of 1.7 mM mPEG thiol, and 4.0 mL of 15 mM
catechol solution were sequentially added to 46.0 mL of Milli-Q water under vigorous
8stirring. The color of the mixture turned from pale yellow to pink to reddish brown, and
finally to bluish brown within 3 min. After allowing the mixture to stir at room temperature
for 2 h, the synthesized AuNPs were pelleted at 800 × g for 10 min, and rinsed at least thrice
with Milli-Q water to obtain a dark blue colloidal dispersion. 46 and 70 nm catechol-
functionalized AuNPs were synthesized in a similar manner except with the volume of 0.1 M
HAuCl4·3H2O solution reduced to 12.5 and 50 µL, respectively.
2.2.3. Synthesis of catechol-functionalized nanourchin-like AuNPs (AuNUs). To synthesize
catechol-functionalized AuNUs with a LSPR excitation wavelength in the NIR region, 20 µL
of 0.1 M HAuCl4·3H2O, 100 µL of 1.0 × 10
-1 mM AgNO3, 28.8 µL of 3.8 × 10
-1 mM
spherical gold seeds, 80 µL of 1.7 mM mPEG thiol, and 300 µL of 15 mM L-dopa or 4-
ethylcatechol were sequentially added to 10 mL of water under vigorous stirring. The reaction
was allowed to proceed at room temperature for 2 h, after which the resultant AuNUs were
purified as described above.
2.3. Characterization of AuNPs: Synthesized AuNPs were characterized by high
resolution TEM (JEOL JEM-2100F) using 200 kV acceleration voltage and by UV-vis-NIR
spectrophotometry (Agilent Cary 6000i). Samples were prepared by drying diluted AuNP
solutions on holey carbon-coated copper grids. The core diameters, tip-to-tip lengths, and
spike aspect ratios of the AuNUs were measured from the TEM images obtained using the
ImageJ software. The core diameters and tip-to-tip lengths were measured twice for each
AuNU, while four spikes per AuNU were measured from the edge of the core to the tip. The
aspect ratio of the spikes were determined by dividing the spike length by the base width of
the spikes. The hydrodynamic diameters and zeta-potentials of the AuNPs were measured by
dynamic light scattering (DLS) using the Zetasizer Nano (Malvern Instrument Ltd.,
Worcestershire, UK) equipped with a He-Ne laser. Scattered light was detected at an angle of
Û DQGDW D VHW WHPSHUDWXUHRI &3DUWLFOH VL]H DQG]HWDSRWHQWLDOPHDVXUHPHQWVZHUH
9repeated for 3 runs per sample, and reported as the mean ± standard deviation of 3 readings.
The nanoparticle concentration of the respective samples equivalent to 1 µg/µL of gold was
determined using NanoSight NS300 nanoparticle tracking analysis (NTA) concentration
measurement upgrade (Malvern Instrument Ltd., Worcestershire, UK). At least 3 independent
samples per type of functionalized AuNP were analyzed for 3 runs per sample, and reported
as the mean ± standard deviation of 3 readings.
To determine the elemental gold concentration of the synthesized AuNPs, an aliquot of
known volume was dissolved in aqua regia, diluted with Milli-Q water, and analyzed using
inductively coupled plasma-atomic emission spectroscopy (ICP-AES; Thermo Scientific
iCAP 6300 Duo). The surface of the functionalized AuNPs was characterized using a Thermo
Scientific K-Alpha+ X-ray Photoelectron Spectrometer (XPS) system operating at 2 × 10-9
PEDUEDVHSUHVVXUH7KLVV\VWHPLQFRUSRUDWHVDPRQRFKURPDWHGPLFURIRFXVHG$O.Į;UD\
VRXUFH KȞ    H9 DQG D  GRXEOH IRFXVLQJ KHPLVSKHULFDO DQDO\VHU ZLWK D '
detector. The X-ray source was operated a 6 mA emission current and 12 kV anode bias. Data
were collected at 200 eV pass energy for survey and 20 eV pass energy for core level and
valence band spectra using an X-ray spot size of 400 µm2. A flood gun was used to minimize
sample charging. Spectra were aligned assuming the C 1s core line to be at a binding energy
of 285.0 eV and normalized to the Au 4f5/2 peak. All data were analyzed using the Avantage
software package.
2.4. Cell culture: Human breast cancer cell lines MCF-7 and MDA-MB-231 were
maintained in MEM, while MDA-MB-453 and MDA-MB-468 were maintained in
DMEM/F12. Both types of cell culture media were supplemented with 10% FBS, 100 U/mL
penicillin, and 100 mg/mL streptomycin. Non-tumorigenic immortalized breast epithelial cell
line MCF-10A was cultured using DMEM/F12 media supplemented with 5% horse serum, 20
ng/mL EGF, 0.5 mg/mL hydrocortisone, 100 ng/mL Cholera toxin, 10 µg/mL insulin 100
10
U/mL penicillin, and 100 mg/mL streptomycin. All cell lines were cultured at 37 ºC under an
atmosphere of 5% CO2 and 95% humidified air.
2.5. Cytotoxicity testing: The effects of AuNF treatment on cell proliferation was
determined using the WST-1 assay. Briefly, MCF-7, MDA-MB-231, and MCF-10A were
seeded onto 96-well plates at a density of 1.2 × 104 cells per well, and allowed to adhere
overnight. The cells were then treated with 0, 5, 15, 50, and 100 µg/mL of Au content for the
various AuNFs (46, 70 and 90 nm) for 48 h. Subsequently, the cells were rinsed twice with
3%6EHIRUHȝ/RIJURZWKPHGLDDQGȝ/RI:67UHDJHQWZHUHDGGHGWRHDFKZHOO
The cells were incubated for 3 h at 37 °C before the absorbance reading were determined at
440 nm using a microplate spectrophotometer. Relative cell proliferation was expressed as
[(Asample-Ablank)/(Auntreated control-Ablank)] ×100%. Data are expressed as mean ± standard
deviations of three replicates per concentration.
2.6. Cellular uptake studies: MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468,
and MCF-10A were respectively seeded onto 12-well plates at a density of 1.8 × 105, 2.5 ×
105, 2.5 × 105, 2.5 × 105, and 1.8 × 105 cells per well, and allowed to adhere overnight. The
incubation media in each well was replaced with cell culture media containing 15 µg/mL Au
content for the various AuNFs (46, 70 and 90 nm). After 12 h incubation at 37 ºC, non-
internalized AuNFs were removed, and the cells were rinsed thoroughly with 1 mL of PBS for
5 times. The cells were then trypsinized, rinsed once with PBS, and pelleted by centrifugation
at 1300 × rpm for 4 min. The cell pellet was digested overnight with 800 µL of aqua regia at
room temperature. The respective samples were subsequently diluted with a known volume of
Milli-Q water before the analysis of Au content using ICP-AES.
The competition assay was performed by co-incubating MCF-7 cells with 0, 2, and 20 mM
of free amino acids phenylalanine or serine and 15 µg/mL gold content of L-dopa
functionalized AuNFs. The cells were co-incubated with free amino acids and the
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functionalized AuNFs for 5 h before being processed as described above for the analysis of
elemental Au content using inductively coupled plasma-mass spectroscopy (ICP-MS; Perkin
Elmer ELAN® DRC-e).
2.7. Preparation of cell samples for TEM imaging: MDA-MB-231 cells were seeded
onto 6-well plates at a density of 6.25 × 105 cells/mL and allowed to adhere overnight. The
cells were incubated with 15 µg/mL gold content of L-dopa- and 4-ethylcatechol-
functionalized AuNFs for 4 and 12 h. Following incubation, the cells were rinsed thrice with 1
× PBS and fixed with 2% glutaraldehyde and 2% formaldehyde in 0.1M sodium cacodylate
(pH 7.4) for 1 h at room temperature. The cells were subsequently stained with 1% osmium
tetroxide for 30 min, rinsed thrice with Milli-Q water, and dehydrated in a series of graded
ethanol (50%, 70%, 95%, and 100% by volume). Aided by centrifugation, the cells were then
infiltrated with increasing concentrations of Epon/acetonitrile resin. The final resin-infiltrated
samples were then polymerized at 100 °C for 30 min. The embedded cells were sectioned to a
thickness of approximately 50 – 100 nm onto a water bath using an ultra-microtome (Leica
EM UC6) equipped with a 35° diamond knife and collected onto 300 mesh copper TEM
grids. Multiple cells (> 100 per sample) from triplicate wells per treatment were observed
using the high-angle annular dark-field-scanning transmission electron microscope (HAADF-
STEM) mode on the FEI Titan 80–300 TEM/STEM operated at 300 kV. The principle of the
HAADF technique is that electrons interacting with the AuNPs undergo Rutherford
scattering, which increases scattering from the particles by a factor ~ Z2.
2.8. Photothermal ablation: Human MDA-MB-231 breast cancer cells were seeded at a
concentration of 3.5 × 104 cells per well in a 96-well plate and cultured for 48 h. The cell
culture media in each well were replaced with fresh media containing 0, 50, and 100 µg/mL
Au content of AuNUs and returned to the incubator for three days. Following incubation, non-
internalized AuNUs in each well were removed and the cells were rinsed three times with 100
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µL of 1 × PBS before 60 µL of phenol red-free MEM containing 10% serum were added to
each well. The cells in each well were subsequently subjected to irradiation using an 808 nm
continuous wave laser at 3.5 W/cm2 for 3 min. After laser exposure, the cells were incubated
for a further 24 h at 37 °C before cell viability was determined using the WST-1 assay. To
investigate the thermal effects of extracellularly applied AuNUs following laser treatment,
phenol-red free cell culture media containing the respective amounts of AuNUs were added to
the cells immediately before laser irradiation. For the LIVE/DEAD® viability/cytotoxicity
assay, 2.1 × 104 cells per well were seeded into each well of a 4-well chamber slide, and
subjected to a similar AuNU treatment and laser exposure protocol as described above, after
which the cells were stained with calcein AM and ethidium homodimer-1 for 30 min at room
temperature before being imaged under a confocal laser scanning microscope (Leica TCS
SP8).
The use of photothermal therapy to sensitize AuNU-treated breast cancer cells to
chemotherapy was studied by the addition of cell culture media containing 83.3 µM cisplatin
and 100 nM docetaxel to each well immediately after laser exposure. The cells were incubated
with the chemotherapeutic agents for a further 24 h at 37 °C before the WST-1 assay was
performed.
2.9. Statistical analysis: The results obtained were analyzed using the two-tailed Student’s
t-test to determine statistical significance (Microsoft Excel). The difference between mean
readings was considered to be statistically significant when P < 0.05.
3. Results and discussion
3.1. Catechol-mediated synthesis and characterization of nanoflower-like AuNPs
(AuNFs). AuNFs were synthesized by first preparing approximately 14 nm gold seeds using
the citrate reduction method (Figure S1), followed by the selective reduction of gold ions onto
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the gold seeds using each of the four different catechols (i.e. L-dopa, D-dopa, dopamine, and
4-ethylcatechol) as a mild reducing-cum-surface capping agent (Figure 1a). Poly(ethylene
glycol) methyl ether thiol (mPEG thiol), which binds to the AuNF surface via oxidative
addition of thiol to Au was included in the synthesis to enhance colloidal stability,
biocompatibility, and blood circulation times in vivo.26-27 The addition of mPEG thiol during
synthesis was indeed found to be essential for obtaining narrowly dispersed AuNPs that were
stable during prolonged storage at 4 °C (> 1 year) as well as the ability to be re-dispersed after
freeze-drying. As expected in a diffusion-controlled atom addition process on pre-formed
metal seeds,28 the addition of increasing amounts of HAuCl4·3H2O gave rise to
correspondingly larger AuNFs with diameters of approximately 46, 70 and 90 nm (by TEM;
Figure 1b, c, and d). As seen from Table S1, the hydrodynamic diameters and zeta-potentials
of the synthesized AuNFs ranged from 55.5 to 116.5 nm and -32.6 to -41.0 mV, respectively.
Importantly, the synthesized AuNFs possessed narrow size distributions which could be seen
from the TEM images (Figure 1b, c, and d) as well as from the small polydispersity indices
3',VRIREWDLQHGIURP'/6PHDVXUHPHQWV7DEOH67KLVSURSHUW\LVIDYRUDEOHIRU
the reliable and accurate interpretation of biological effects as differently sized nanoparticles
within a given formulation may elicit disparate cell interactions and toxicity.29 The
synthesized AuNFs gave rise to an intense UV-vis absorption peak ranging from 563 to 649
nm, which red-shifted with size for each functionalization type (Figure S2a).
High resolution TEM (HRTEM) images revealed interplanar distances of approximately
0.233 nm and 0.206 nm, which are close to the characteristic values reported for Au (111) and
(200) lattice planes, respectively,30 hence confirming that the multi-branched AuNFs are
composed of Au (Figure S3). Additionally, the successful conjugation and presentation of the
respective catechols on the surface of the AuNFs was confirmed by XPS analysis. Survey
spectra of the 90 nm catechol-functionalized AuNFs showed a strong signal from Au 4f and
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depending on the catechol, varying signals from C, N and O 1s (Figure S4a). A small amount
of Si, which was due to the carrier substrate used, was also observed. For all samples, the Au
4f core level is at a binding energy of 84 eV and shows a spin orbit split of 3.6 eV, both
typical for metallic Au (Figure S4b). The C and N 1s core levels are ideal to identify the type
of catechol on the surface of the AuNFs. For the C 1s spectrum 3 distinct contributions can be
identified: C-C and C=C environments at 285.0 eV, C-OH and C-NH2 environments at 286.3
eV, and the carboxylic group at 289.0 eV. AuNFs synthesized using L- and D-dopa were
found to possess both carboxylic acid and amino groups, while those prepared with dopamine
showed only the expected contributions from the amino group (Figure S4c and d). As
expected, both signals were absent in the spectrum obtained for the AuNFs synthesized using
4-ethylcatechol.
To evaluate their colloidal stability, L-dopa functionalized AuNFs were incubated in
various biologically relevant media including deionized water, 1 × PBS, cell culture media
containing 10% v/v serum, and 100% serum and monitored for changes in hydrodynamic
diameters by DLS over time. The AuNFs were incubated at 37 °C with continuous shaking to
mimic blood circulation. As seen in Figure S5, the L-dopa-functionalized AuNFs remained
stable in deionized water and 1 × PBS, with minimal changes in hydrodynamic diameters,
which were approximately 115 and 111 nm, respectively over three days of incubation.
Similarly, no shift in the UV-vis absorbance peaks was observed when the AuNFs were
dispersed in 1 × PBS (Figure S2b). In serum-containing cell culture media, however, the
AuNFs gradually increased in size from 125.9 ± 0.8 nm (t = 0 h) to 167.4 ± 0.5 nm (t = 72 h).
A similar observation was made for the AuNFs incubated in 100% serum, with a higher initial
diameter of 164.3 ± 2.5 nm at 0 h increasing to 186.0 ± 0.4 nm by 72 h. The increase in
hydrodynamic diameters of the AuNFs in serum-containing media and 100% serum could
likely be attributed to the passive adsorption of serum proteins onto the nanoparticle surface.
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Despite the size increment, the hydrodynamic diameter of the AuNFs began to plateau at 72
h; and the resultant size of the AuNFs remained less than 200 nm – a size which still falls
within the desired size range for passive tumor accumulation via the EPR effect and the
promotion of cellular uptake. In addition to the relatively small sizes observed, the PDIs of the
AuNFs in the different media were also found to remain small (< 0.15) and relatively constant
with time, hence suggesting that no uncontrolled aggregation of the AuNFs occurred.
3.2. Synthesis and characterization of sea urchin-like AuNPs (AuNUs) with NIR
absorbance. Besides being able to control the size of the AuNFs synthesized using catechols
in the seed-mediated approach (Figure 1b-d), the versatility of this system to tune the shape
and therefore the LSPR peak of the multi-branched nanoparticles to the biologically
transparent NIR region for optimal PTT was further demonstrated. This was achieved through
the introduction of Ag+ as a shape-directing agent during the seeded growth process.23-25, 31-32
In the presence of gold seeds, Ag+ is known to undergo reduction on gold surfaces at a
potential less than the standard reduction potential of Ag+/Ag0 in a phenomenon known as
‘under-potential deposition’.25, 32-33 At low concentrations of added Ag+, the reduced Ag
atoms have been found to preferentially deposit on the more open Au (110) facets thereby
protecting them from further growth while promoting anisotropic growth of Au atoms on the
(111) and (100) planes.32 As seen from Figure 2a, the introduction of Ag+ enhanced the aspect
ratio of the branches formed, giving rise to narrowly dispersed AuNUs capped with L-dopa
and PEG on the surface. From the TEM images, the mean diameter of the L-dopa
functionalized AuNU core was found to be 83.9 ± 4.4 nm (Figure 2a insert), while tip-to-tip
and spike lengths were found to be 121.1 ± 9.8 nm and 29.6 ± 7.6 nm, respectively (Table
S2). The hydrodynamic diameter, PDI, and zeta-potential of the L-dopa functionalized AuNU
were determined using DLS to be 155.0 ± 1.0 nm, 0.22, and -15.1 ± 0.6 mV, respectively
(Table S3). A selected area (electon) diffraction (SAED) pattern obtained from the AuNU
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branch shows a diffraction pattern with rings corresponding to the (111), (200), (220), (311),
and (222) reflections of the face-centered-cubic (fcc) structure of gold (Figure 2b). With an
increase in the aspect ratio of the branches, the L-dopa functionalized AuNUs were found to
exhibit a broader plasmon spectrum, with a dominant longitudinal plasmon resonance peak
that was red-shifted to 808 nm in the NIR region and with a weak transverse peak at ~ 527 nm
(Figure 2c). The presence of primary amine and carboxylic acid groups of the L-dopa
molecules on the surface of the multi-branched AuNUs were confirmed using XPS analysis
(Figure 2d and e). Control AuNUs were also synthesized using 4-ethylcatechol and were
found to have similar morphological and optical properties (Table S2, S3, and Figure S6). As
expected, XPS analysis confirmed the absence of both primary amine and carboxylic acid
groups on the surface of the 4-ethylcatechol functionalized AuNUs (Figure 2d and e). The
Au:Ag ratio on the surface of the AuNUs was determined from Au 4d and Ag 3d core levels
to be 98:2 for both samples (Figure 2f).
A major limitation in the development of anisotropic AuNPs such as nanorods,
nanoprisms, and nanostars for photothermal applications lies in the undesirable ageing
phenomenon in which the AuNPs tend to rearrange into thermodynamically favorable spheres
during long term storage or laser-induced heating,34 resulting in the loss of original
nanoparticle shape, aggregation of nanoparticles, and a resultant blue shift in the UV-vis
absorption curve. This event has been attributed to the higher surface energy of gold atoms
arising from the larger surface area in anisotropic AuNPs. In this study, we found that the
catechol and PEG coating on the surface of the multi-branched AuNUs was able to effectively
minimize the ageing process as seen from the unchanged UV-vis absorption spectrum over a
period of 3 months (Figure S6b).
3.3. Cytotoxicity and LAT-1 targeted cellular uptake. The cytotoxicity of the
functionalized AuNFs was first evaluated in the human breast cancer cell lines MCF-7 and
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MDA-MB-231 as well as the non-tumorigenic immortalized breast epithelial MCF-10A cell
line. No overt cytotoxicity was induced by all the functionalized AuNFs of various sizes even
at supraphysiological concentrations of up to 100 µg/mL equivalent gold content in all three
cell lines tested (Figure 3 and Figure S7). These results thus demonstrate that the
functionalized AuNFs are biocompatible and are suitable for biomedical applications.
To evaluate the LAT-1 targeting efficiency, a panel of breast cancer cell lines including
MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468, and the non-tumorigenic MCF-10A
cell line were incubated with the respective catechol-functionalized AuNFs and quantified for
intracellular gold content using ICP-AES. For each of the three sizes of AuNFs tested, it was
observed that the L- and D-dopa functionalized AuNFs mediated significantly higher uptake
in all four breast cancer cell lines when compared to the dopamine and 4-ethylcatechol
functionalized AuNF controls (P < 0.01; Figure 4a-c). For instance, in the triple negative
MDA-MB-231 cell line, it was found that approximately 17% of the added dose of both the
90 nm L-dopa and D-dopa functionalized AuNFs were taken up by the cells while < 1% of
the dopamine and 4-ethylcatechol functionalized AuNFs were internalized (Figure 4b). The
higher uptake of both the L- and D-dopa functionalized AuNFs in the breast cancer cell lines
was consistent with reports on the ability of the LAT-1 to transport both the L and D isomers
of bulky or branched amino acids in cancer cells.35-36 Notably, minimal uptake of L- and D-
dopa functionalized AuNFs was observed in the non-tumorigenic MCF-10A cell line, hence
demonstrating the selectivity of the L- and D-dopa functionalized AuNFs towards breast
cancer cells (Figure 4d). It is also important to note that the LAT-1 targeting capabilities of
the L- and D-dopa functionalized AuNFs appear to be preserved despite the possible surface
adsorption of serum proteins on the nanoparticles as discussed in Section 3.1 (Figure S5).
To further investigate the mode of cellular uptake and intracellular distribution of the L-
dopa and 4-ethylcatechol functionalized AuNFs, thin sections of treated MDA-MB-231 cells
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were prepared and imaged using HAADF-STEM. After 4 hours treatment, the L-dopa
functionalized AuNFs were observed on the plasma membrane and at invaginations of the
plasma membrane (Figure 5a and Figure S8). The L-dopa functionalized AuNFs were found
predominantly as clusters within vesicular structures inside the cells, hence suggesting an
endocytic mode of cellular uptake (Figure 5b and c) after both 4 and 12 hours treatment. In
stark contrast, very few of the non-targeting 4-ethylcatechol functionalized AuNFs were
observed within the cells (Figure 5d). The endocytic mode of uptake for the L- and D-dopa
functionalized AuNFs was further confirmed by the significant decrease in the amount of
AuNFs internalized when the incubation temperature was reduced from 37 °C to 4 °C (P <
0.05; Figure S9). In the literature, the clathrin-independent mode of endocytosis has been
reported for the internalization of heterodimeric LAT-1-4F2hc complexes, which are taken
into the cells via distinct vesicles that are subsequently transferred to early endosomes for
sorting.37-38 It is believed that the mild acidic pH of the early endosomes then triggers
conformational changes in the protein complex causing release of its cargo, hence enabling
the transporter to be recycled back to the plasma membrane via tubular endosomes.
The role of LAT-1 in mediating uptake of the L-dopa functionalized AuNFs was
investigated in a competition assay where the uptake of AuNFs by the MCF-7 breast cancer
cells was determined in the presence of previously reported LAT-1 substrates phenylalanine
(Phe) or serine (Ser).35 In the presence of the high affinity substrate Phe (Km = 14.2 µM), a
dose-dependent decrease in the amount of L-dopa functionalized AuNFs internalized was
observed, with uptake reduced to 84% and 70% of the control in the presence of 2 and 20 mM
of Phe, respectively (Figure 6a; P < 0.05). The low affinity substrate Ser, on the other hand,
did not induce significant decrease in the uptake of L-dopa functionalized AuNFs. As the
concentrations of free amino acids and AuNFs used in this experiment did not induce overt
cytotoxicity (Figure 3 and 6b), it is likely that the free Phe competed with the L-dopa
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functionalized AuNFs for interaction with the LAT-1, thereby leading to a reduction in
nanoparticle uptake.
3.4. Effect of AuNP geometry on cellular uptake. As the size and shape of nanoparticles
play an important role in influencing their biological properties,39 we next evaluated the effect
of particle size on the uptake of AuNFs using the MDA-MB-231 breast cancer cells. The
nanoparticle concentration for a known gold content of each type of AuNF was first estimated
using NTA (Table S1) and an approximately same number (~ 1.1 × 1010 particles per well) of
each of the AuNFs was incubated with the cells for 12 h. For each type of functionalization, a
size-dependent uptake of the AuNFs was found to occur in the following order: 90 nm > 70
nm > 46 nm (P < 0.05; Figure S10). For instance, an increase in the diameter of the L-dopa
functionalized AuNFs from 46 to 70 and 90 nm, resulted in 3.0- and 3.7-fold increase in the
number of particles taken up per cells, respectively. The influence of nanoparticle shape on
the uptake of the AuNPs was further evaluated using the functionalized AuNFs and AuNUs
with similar core diameters of approximately 90 and 84 nm, respectively (Figure 1d, 2a insert
and Table S2). Whilst the cancer targeting properties of both the L-dopa functionalized
AuNFs and AuNUs were preserved when compared to the 4-ethylcatechol functionalization,
an increase in the aspect ratios of the nanoparticle branches from the flower-like to urchin-like
morphology led to a slight decrease in cellular uptake at both concentrations tested (P < 0.01;
Figure S11). This result is in agreement with previous studies in which spherical AuNPs or
AuNPs having a shape closer to a sphere were found to promote greater cellular uptake when
compared to star-shaped or urchin-like AuNPs in various cell types.39
3.5. Photothermal properties of functionalized AuNUs. The photothermal properties of
the L-dopa- and 4-ethylcatechol-functionalized AuNUs were investigated as a function of
concentration during exposure to an 808 nm continuous wave laser with a power density of
3.5 W/cm2 for 3 min. As shown in Figure 7a, laser irradiation of dispersions containing L-
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dopa functionalized AuNUs resulted in a gradual dose-dependent rise in temperature, with the
highest temperature increase of 21 °C recorded at 50 µg/mL, while no significant temperature
rise was observed with Milli-Q water. A similar heating profile was also obtained for the 4-
ethylcatechol functionalized AuNUs, hence demonstrating that the type of coating did not
affect the photothermal properties of the AuNUs (Figure S12). In addition, the laser
irradiation of the L-dopa and 4-ethylcatechol functionalized AuNUs did not result in
significant changes to the core diameter, tip-to-tip length, and the aspect ratio of the branched
structures (Table S2). These results thus suggest that the coating of the multi-branched
AuNUs with L-dopa or 4-ethylcatechol and PEG was sufficient to maintain the structural
stability of the AuNUs during photothermal heating and could potentially reduce the need for
repeated nanoparticle dosing during the treatment course.
3.6. Selective photothermal ablation of breast cancer cells. In order to first simulate a
situation whereby malignant breast cancer cells are exposed to photothermal agents in the
interstitial fluids in vivo, L-dopa functionalized AuNUs were added to each well with cells
adhered at the bottom and immediately subjected to NIR laser irradiation at 3.5 W/cm2.
Consistent with the thermal profiles observed earlier, the bulk heating of the extracellular
medium resulted in a concentration-dependent decrease in MDA-MB-231 cell viability; with
cell viability decreased to 75% at 5 µg/mL, and < 1% from 15 µg/mL and above (P < 0.05 or
0.01; Figure 7b). To demonstrate targeted photothermal ablation of breast cancer cells by the
L-dopa functionalized AuNUs, MDA-MB-231 cells were pre-treated with various
concentrations of AuNUs for three days. Following pre-treatment, only a small amount of
non-internalized L-dopa functionalized AuNUs was found to remain in the extracellular
medium as compared to the 4-ethylcatechol functionalized AuNUs treated wells (Figure
6D$IWHUULQVLQJWKHFHOOVWKRURXJKO\WRUHPRYHH[WUDFHOOXODU$X18VRIWKHDGGHG
GRVHRI/GRSDIXQFWLRQDOL]HG$X18VDQGRIWKHHWK\OFDWHFKROIXQFWLRQDOL]HG$X18V
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were found to be taken up by the cells (Figure S13b). Optical micrographs of the cells before
and after laser irradiation were also recorded. Figure S14b and c shows the accumulation of
dark L-dopa functionalized AuNUs granules within cells, while no nanoparticle clusters were
visible in the untreated and 4-ethylcatechol functionalized AuNUs treated cells (Figure S14a,
d, and e). Immediately after laser irradiation, the cells that have internalized L-dopa
functionalized AuNUs appeared rounded up whereas minimal or no changes in cell
morphology were observed for the untreated cells and cells treated with 4-ethylcatechol
functionalized AuNUs (right panels of Figure S14b and c vs. Figure S14a, d, and e). An
evaluation of the cell viability 24 h after laser irradiation showed that cells that have been pre-
treated with 50 and 100 µg/mL L-dopa functionalized AuNUs had significantly reduced cell
viability of 30% and 16%, respectively (P < 0.01; Figure 7c). In contrast, cells treated with
the non-targeting 4-ethylcatechol functionalized AuNUs were fully viable at the same
irradiation dosage (P > 0.05; Figure 7d), hence clearly demonstrating the ability of the L-dopa
functionalized AuNUs to mediate selective photothermal ablation of breast cancer cells. In the
absence of laser exposure, cells that were separately treated with L-dopa- and 4-ethylcatechol-
functionalized AuNUs were not found to be toxic at the dosages tested. The selective PTT
mediated by the L-dopa functionalized AuNUs could be further demonstrated by the confined
detachment of non-viable cells 24 h after laser irradiation, giving rise to a relatively empty
zone within the laser spot (outlined by white dotted line), while cells outside the zone of laser
irradiation remained largely viable (Figure 7e). On the other hand, the cell monolayer treated
with the non-targeting 4-ethylcatechol functionalized AuNUs remained fully intact and viable
after laser treatment as evidenced from the uniform green fluorescent staining of live cells by
the cell permeant calcein AM dye as well as absence of red fluorescent staining of non-viable
cells by the ethidium homodimer-1 dye (Figure 7f). These results thus demonstrate that the
localized laser irradiation of cells that have internalized the LAT-1 targeting AuNUs serves as
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a secondary form of targeting to overcome unwanted side effects frequently observed with
traditional chemotherapy and hyperthermia therapy. As a proof-of-concept for the use of L-
dopa functionalized AuNU-mediated PTT to sensitize cancer cells to conventional
chemotherapy, the pre-treated MDA-MB-231 breast cancer cells were first subjected to laser
irradiation and subsequently exposed to cisplatin (Cis) and docetaxel (DTX), which are first-
line chemotherapeutic agents used in the clinical treatment of TNBC. At the highest dose of
L-dopa functionalized AuNU used for pre-treatment, the cells demonstrated a cell viability of
16% when subjected to PTT alone (Figure 8). Cells treated with Cis alone had cell viability of
61%. The combination of PTT and Cis led to a significant reduction in cell viability to 4% (P
< 0.05), which was less than the 9.8% cell viability expected if the combination effect was
additive, hence suggesting synergistic effects.40 Similarly, treatment of the cells with DTX
alone resulted in a cell viability of 84%. The combination of PTT and DTX at the 100 µg/mL
pre-treatment dose of L-dopa functionalized AuNUs used led to a significant reduction in cell
viability to 1% (P < 0.01), which was again lower than the 13.4% cell viability expected in
the case of additive effects. These results were thus consistent with previous reports in which
PTT was found to increase membrane permeability thereby leading to enhanced drug
accumulation and cytotoxicity in cancer cells.4, 40
4. Conclusions
In this study, a simple and versatile method was developed for the synthesis of multi-
branched AuNPs with active cancer targeting capabilities via the LAT-1. By utilizing
catechol-containing LAT-1 ligands in the seed mediated reduction of gold ions,
monodispersed nanoflower-like AuNPs with excellent stability, biocompatibility, and
targeting to a panel of breast cancer cell lines even in the presence of serum-containing media
were obtained. The direct synthesis of cancer targeting multi-branched AuNPs using LAT-1
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ligands circumvents the need for cytotoxic surfactants as well as additional conjugation
procedures, hence potentially offering time and cost savings for the large scale production of
biofriendly AuNPs. Additionally, the introduction of silver ions during synthesis gave rise to
sea urchin-like AuNPs (AuNUs) with strong absorbance in the NIR window, which enabled
them to be used in the selective photothermal ablation of the triple negative MDA-MB-231
breast cancer line. In addition, the PTT mediated by the L-dopa functionalized AuNUs
sensitized breast cancer cells to the cytotoxic effects of conventional chemotherapeutic agents
cisplatin and docetaxel. Taken together, the cancer targeting L- or D-dopa functionalized
AuNUs may have potential to be used for the in vivo targeted photothermal ablation of breast
cancers, especially against the triple negative subtype, for which there is currently no targeted
therapy. As LAT-1 is frequently overexpressed in numerous proliferating tumors, this
technology may also have broad applications for the targeted PTT of other cancer types.
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Figure 1. (a) Catechols employed in the synthesis and functionalization of multi-branched
AuNPs in this study. (b-d) TEM images of catechol-functionalized AuNFs that were prepared
using (b) 12.5, (c) 50, and (d) 100 µL of 0.1M HAuCl4·3H2O. Particle size distribution was
determined from the obtained TEM images using the ImageJ software.
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Figure 2. Representative (a) TEM image with core measurement (insert), (b) selected area
electron diffraction (SAED) pattern, and (c) UV-vis absorbance spectrum of L-dopa
functionalized AuNUs with LSPR peak absorbance tuned towards the NIR region. X-ray
photoelectron spectroscopy (XPS) spectra obtained for L-dopa and 4-ethylcatechol
functionalized AuNUs indicating (d) C 1s, (e) N, and (f) Au 4d and Ag 3d core levels.
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Figure 3. Effect of 90 nm catechol-functionalized AuNFs treatment on cell proliferation in (a)
MCF-7, (b) MDA-MB-231, and (c) MCF-10A determined using WST-1 assay.
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Figure 4. Uptake of catechol-functionalized AuNFs by breast cancer cell lines (a) MCF-7, (b)
MDA-MB-231, (c) MDA-MB-453 and MDA-MB-468 (90 nm), and (d) non-tumorigenic
MCF-10A treated with 15 µg/mL of AuNFs for 12 h determined using ICP-AES. Results
represent mean ± standard deviation from at least two independent experiments performed in
triplicates.
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Figure 5. HAADF-STEM images of MDA-MB-231 cells after incubation with 15 µg/mL
equivalent gold content of 90 nm L-dopa- and 4-ethylcatechol-functionalized AuNFs. (a) L-
dopa functionalized AuNFs aligned with the plasma membrane and at membrane
invaginations (i); individual L-dopa functionalized AuNFs at the plasma membrane (ii). (b)
Accumulation of L-dopa functionalized AuNFs inside vesicles after 4 h treatment; i-ii are
higher magnification images of the boxed regions in b showing clusters of particles in close
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proximity to the mitochondria (i), and within vesicles (ii). (c) Clusters of L-dopa
functionalized AuNFs inside the cells after 12 h treatment; i-ii are higher magnification
images of the boxed regions in b showing clusters of AuNF within vesicles. (d)
Representative cell section showing minimal or no 4-ethylcatechol functionalized AuNF
uptake even after 12 h treatment. ES – extracellular space, V – vesicle, M – mitochondria, ER
– endoplasmic reticulum, C – cytoplasm, N – nucleus, PM – plasma membrane, MV –
membrane invagination.
33
Figure 6. (a) Competitive inhibition of L-dopa functionalized AuNF uptake in MCF-7 in the
presence of free LAT-1 ligands following 5 h incubation (* P < 0.01; ** P < 0.05). Results
represent mean ± standard deviation from three independent experiments performed in
triplicates. (b) Cell viability of MCF-7 following free amino acid treatment for 5 h.
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Figure 7. Photothermal effects of functionalized AuNUs following laser treatment. (a)
Heating curve of L-dopa functionalized AuNUs following irradiation with 808 nm laser at 3.5
W/cm2. (b) Cell viability of triple negative MDA-MB-231 breast cancer cell line exposed to
increasing concentrations of extracellular L-dopa functionalized AuNUs added just before
laser irradiation. * P < 0.05; ** P < 0.01 relative to untreated control. Cell viability of MDA-
MB-231 cells that have internalized (c) L-dopa functionalized AuNUs and (d) 4-ethylcatechol
functionalized AuNUs with (w/) and without (w/o) laser exposure. ** P < 0.01. Confocal
scanning laser microscopy images after laser irradiation of MDA-MB-231 that have
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internalized (e) L-dopa functionalized AuNUs and (f) 4-ethylcatechol functionalized AuNUs.
Live cells are stained green while dead cells appear red.
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Figure 8. Sensitization of MDA-MB-231 cells to 83 µM cisplatin (Cis) and 100 nM docetaxel
(DTX) following laser irradiation of cells pre-treated with L-dopa functionalized AuNUs at
the indicated concentrations (in µg/mL). * P < 0.05; ** P < 0.01 relative to corresponding
laser treated control without the addition of anti-cancer drug.
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